Immunization, Hib3 in New Zealand
New Zealand: Immunization, Hib3 was 89.0% in 2024. ▲ Rising
Immunization, Hib3 in New Zealand, 1997–2024
Source: WHO and UNICEF (http://www.who.int/immunization/monitoring_surveillance/en/). Measured in % of children ages 12-23 months.
Analysis
The most recent figure for immunization, hib3 in New Zealand is 89.0%, measured in 2024.
That represents a change of up 1.1% on the previous year and down 4.3% over ten years.
Over the whole period, immunization, hib3 in New Zealand peaked at 98.0% in 2009 and was at its lowest, 78.0%, in 2007.
New Zealand ranks 108th of 191 countries on this measure, in the middle of the range.
The long-run direction has been consistently rising across the 28 years of available data.
Immunization, Hib3 in New Zealand, year by year
| Year | % of children ages 12-23 months | Change |
|---|---|---|
| 1997 | 86.0% | — |
| 1998 | 81.0% | -5.8% |
| 1999 | 88.0% | +8.6% |
| 2000 | 90.0% | +2.3% |
| 2001 | 90.0% | +0.0% |
| 2002 | 88.0% | -2.2% |
| 2003 | 85.0% | -3.4% |
| 2004 | 83.0% | -2.4% |
| 2005 | 80.0% | -3.6% |
| 2006 | 80.0% | +0.0% |
| 2007 | 78.0% | -2.5% |
| 2008 | 86.0% | +10.3% |
| 2009 | 98.0% | +14.0% |
| 2010 | 89.0% | -9.2% |
| 2011 | 94.0% | +5.6% |
| 2012 | 93.0% | -1.1% |
| 2013 | 92.0% | -1.1% |
| 2014 | 93.0% | +1.1% |
| 2015 | 92.0% | -1.1% |
| 2016 | 92.0% | +0.0% |
| 2017 | 93.0% | +1.1% |
| 2018 | 92.0% | -1.1% |
| 2019 | 91.0% | -1.1% |
| 2020 | 92.0% | +1.1% |
| 2021 | 90.0% | -2.2% |
| 2022 | 89.0% | -1.1% |
| 2023 | 88.0% | -1.1% |
| 2024 | 89.0% | +1.1% |
New Zealand compared with similar countries
- New Zealand's 89.0% is below the median for high income countries, which is 95.0%, 94% of the median. (62 countries reporting)
- New Zealand's 89.0% is below the median for East Asia & Pacific, which is 93.0%, 96% of the median. (29 countries reporting)
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 1990s | 85.0% | 81.0% | 88.0% | 3 |
| 2000s | 85.8% | 78.0% | 98.0% | 10 |
| 2010s | 92.1% | 89.0% | 94.0% | 10 |
| 2020s | 89.6% | 88.0% | 92.0% | 5 |
Countries ranked near New Zealand
More health data for New Zealand
- Un projection of annual infant deaths, annual growth rate -2.94 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate -0.4815 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 1,116 deaths per 1,000 people (2090)
- Number of infants who die before age 1 33 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 0 (2025)
- Population ages 00-04, female, annual growth rate -0.1187 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.0277 units per person (2025)
- Population ages 00-04, male, annual growth rate 0.018 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0 units per US$ of GDP (2025)
Frequently asked questions
- What is immunization, hib3 in New Zealand?
- Immunization, hib3 in New Zealand was 89.0% in 2024, according to WHO and UNICEF (http://www.who.int/immunization/monitoring_surveillance/en/).
- What is the highest immunization, hib3 recorded in New Zealand?
- The highest recorded value was 98.0% in 2009.
- What is the lowest immunization, hib3 recorded in New Zealand?
- The lowest recorded value was 78.0% in 2007.
- How does New Zealand rank for immunization, hib3?
- New Zealand ranks 108th out of 191 countries with data for 2024.
- Is immunization, hib3 rising or falling in New Zealand?
- Over the last ten years it is down 4.3%. The long-run trend across the full record is rising.
- Where does this New Zealand data come from?
- The figures come from WHO and UNICEF (http://www.who.int/immunization/monitoring_surveillance/en/), published as part of Immunization, Hib3 (% of children ages 12-23 months). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 28 observations, free to reuse under CC BY 4.0 (World Bank Open Data).
About this data
Child immunization, Hib3, measures the percentage of children ages 12-23 months who received Hib3 vaccinations before 12 months or at any time before the survey. A child is considered adequately immunized against Hib3 after receiving three doses of Haemophilus influenzae type b vaccine.